Latest Asx News

Athena Resources has reported outstanding assay and metallurgical results from its Byro South drilling program, revealing high-quality magnetite mineralisation with iron grades exceeding 68%. The company is now advancing towards a maiden resource estimate that could reshape the economics of its Byro Magnetite Project.

Aquirian Limited reports a 16.7% revenue increase alongside key operational advances at its Wubin facility and new leadership appointments, signaling strong momentum in mining services and technology.

Antares Metals has identified several high-grade uranium prospects at its Mt Isa North Project, with surface samples reaching nearly 2,000 ppm U3O8 and plans underway for maiden drilling at Queens Gift.

Antipa Minerals reports exceptional gold and copper assay results from its Minyari Project, reinforcing resource growth and advancing pre-feasibility studies.

Amplitude Energy has launched the retail component of its fully underwritten entitlement offer, aiming to raise approximately A$20 million to support key growth projects including the expansion of the East Coast Supply Project and the potential restart of Patricia Baleen.

Global X Management (AUS) Limited has released updated estimated distribution amounts for 12 of its ETFs listed on the ASX AQUA Market, covering the September 2025 period. The announcement includes key dates and confirms distribution reinvestment plan eligibility for all funds.

Variscan Mines has successfully completed the majority of the second tranche of its $2.5 million capital raise, issuing over 330 million shares and nearly 200 million options to support its zinc-lead project in Spain.

Southern Palladium has responded to an ASX price query denying undisclosed information behind its recent share price rise, instead pointing to positive commodity price trends and ongoing project developments.

RAM Essential Services Property Fund (REP) reports a Q1 FY26 distribution in line with guidance and reaffirms its full-year yield target while progressing its strategic transition to a healthcare-focused REIT.

Locksley Resources has completed its second tranche placement with Tribeca, significantly strengthening its cash reserves to support its U.S. mine-to-market ambitions.

Bio-Gene Technology Limited has addressed ASX concerns over the timing of its announcement on promising Flavocide efficacy data, confirming compliance with continuous disclosure rules after receiving final presentation materials from Purdue University.

OncoSil Medical has affirmed the materiality of the PANCOSIL Phase 1-2 trial results and detailed its compliance with ASX disclosure rules following the data presentation at CIRSE 2025.